BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33039895)

  • 1. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
    Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
    Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1.
    Kim SH; Kim SJ; Park J; Joe Y; Lee SE; Saeidi S; Zhong X; Kim SH; Park SA; Na HK; Chung HT; Surh YJ
    Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33809707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth.
    Munir MT; Kay MK; Kang MH; Rahman MM; Al-Harrasi A; Choudhury M; Moustaid-Moussa N; Hussain F; Rahman SM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diverse Roles of Heme Oxygenase-1 in Tumor Progression.
    Luu Hoang KN; Anstee JE; Arnold JN
    Front Immunol; 2021; 12():658315. PubMed ID: 33868304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer.
    Luo Q; Zheng N; Jiang L; Wang T; Zhang P; Liu Y; Zheng P; Wang W; Xie G; Chen L; Li D; Dong P; Yuan X; Shen L
    Cancer Sci; 2020 Nov; 111(11):4000-4011. PubMed ID: 32798273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages.
    Ahirwar DK; Charan M; Mishra S; Verma AK; Shilo K; Ramaswamy B; Ganju RK
    Cancer Res; 2021 Oct; 81(20):5255-5267. PubMed ID: 34400395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages.
    Alaluf E; Vokaer B; Detavernier A; Azouz A; Splittgerber M; Carrette A; Boon L; Libert F; Soares M; Le Moine A; Goriely S
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-498 inhibits autophagy and M2-like polarization of tumor-associated macrophages in esophageal cancer via MDM2/ATF3.
    Li D; Yan M; Sun F; Song J; Hu X; Yu S; Tang L; Deng S
    Epigenomics; 2021 Jul; 13(13):1013-1030. PubMed ID: 34114479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Polarization States in the Tumor Microenvironment.
    Boutilier AJ; Elsawa SF
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme catabolism by tumor-associated macrophages controls metastasis formation.
    Consonni FM; Bleve A; Totaro MG; Storto M; Kunderfranco P; Termanini A; Pasqualini F; Alì C; Pandolfo C; Sgambelluri F; Grazia G; Santinami M; Maurichi A; Milione M; Erreni M; Doni A; Fabbri M; Gribaldo L; Rulli E; Soares MP; Torri V; Mortarini R; Anichini A; Sica A
    Nat Immunol; 2021 May; 22(5):595-606. PubMed ID: 33903766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
    Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.
    Leonard F; Curtis LT; Hamed AR; Zhang C; Chau E; Sieving D; Godin B; Frieboes HB
    Cancer Immunol Immunother; 2020 May; 69(5):731-744. PubMed ID: 32036448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc00514 promotes breast cancer metastasis and M2 polarization of tumor-associated macrophages via Jagged1-mediated notch signaling pathway.
    Tao S; Chen Q; Lin C; Dong H
    J Exp Clin Cancer Res; 2020 Sep; 39(1):191. PubMed ID: 32943090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cordyceps militaris polysaccharide converts immunosuppressive macrophages into M1-like phenotype and activates T lymphocytes by inhibiting the PD-L1/PD-1 axis between TAMs and T lymphocytes.
    Bi S; Huang W; Chen S; Huang C; Li C; Guo Z; Yang J; Zhu J; Song L; Yu R
    Int J Biol Macromol; 2020 May; 150():261-280. PubMed ID: 32044366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment.
    Jesser EA; Brady NJ; Huggins DN; Witschen PM; O'Connor CH; Schwertfeger KL
    Breast Cancer Res; 2021 Nov; 23(1):104. PubMed ID: 34743736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 tumor-associated macrophages resist to oxidative stress through heme oxygenase-1 in the colorectal cancer tumor microenvironment.
    Ito M; Mimura K; Nakajima S; Okayama H; Saito K; Nakajima T; Kikuchi T; Onozawa H; Fujita S; Sakamoto W; Saito M; Momma T; Saze Z; Kono K
    Cancer Immunol Immunother; 2023 Jul; 72(7):2233-2244. PubMed ID: 36869896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor growth and alteration of associated macrophage cell type by an HO-1 inhibitor in breast carcinoma-bearing mice.
    Deng R; Wang SM; Yin T; Ye TH; Shen GB; Li L; Zhao JY; Sang YX; Duan XG; Wei YQ
    Oncol Res; 2013; 20(10):473-82. PubMed ID: 24308158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
    Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
    Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.
    Zhou L; Tian Y; Guo F; Yu B; Li J; Xu H; Su Z
    Cancer Immunol Immunother; 2020 May; 69(5):835-846. PubMed ID: 32062693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.